Medical News

RSS

Researchers suggest possible novel target for seizure-blocking medicines

Researchers in the biomedical engineering department at Case Western Reserve University have found that epileptic activity can spread through a part of the brain in a new way, suggesting a possible novel target for seizure-blocking medicines.

24 Jan 2014

Medicaid 'death debt' causes some to step away from coverage

A little-known aspect of Medicaid allows states, in certain cases, to recoup medical costs by claiming deceased people's homes, which is causing some people to avoid coverage, even those who are newly eligible under the health law's expanded eligibility.

24 Jan 2014

Early onset of dietary treatment may slow down progression of Alzheimer's disease

New research findings indicate that an early onset of dietary treatment may slow down the progression of Alzheimer's disease. The study was conducted on mice, and the results will be published in the February issue of Journal of Nutritional Biochemistry. Researchers from the University of Eastern Finland played a key role in the study, which was carried out as part of the LiPiDiDiet project funded by the European Union.

24 Jan 2014

New approaches for emerging technique in diagnostic imaging for breast cancer-MRI with NIRS

Dartmouth engineers and radiologists are developing new approaches for an emerging technique in diagnostic imaging for breast cancer-MRI with near-infrared spectroscopy as reported in the journal Academic Radiology, February 2014.

24 Jan 2014

TherapeuticsMD starts TX 12-002-HR phase 3 clinical trial for secondary amenorrhea

TherapeuticsMD, Inc., a women's healthcare company, announced today that it has initiated the SPRY Trial, a randomized, placebo-controlled phase 3 clinical trial designed to evaluate the safety and efficacy of TX 12-002-HR, its oral progesterone candidate for secondary amenorrhea, a condition treated to maintain fertility in young premenopausal women.

24 Jan 2014

Bristol-Myers Squibb fourth quarter 2013 revenues increase 6% to $4.4 billion

Bristol-Myers Squibb Company today reported results for the fourth quarter and full year of 2013. The fourth quarter was highlighted by the company's announcement to sell its diabetes business as part of the continued evolution of its successful BioPharma strategy to a specialty care model. The company achieved important regulatory milestones in the quarter for Eliquis in the U.S., daclatasvir/asunaprevir in Japan, daclatasvir in Europe and Farxiga in the U.S. In addition, the company provided financial guidance for 2014.

24 Jan 2014

Political cartoon: 'Friends With Benefits?'

Kaiser Health News provides a fresh take on health policy developments with "Friends With Benefits?" by Mike Lester.

24 Jan 2014

FDA approves Miltenyi Biotec's CliniMACS CD34 Reagent System for prevention of GVHD

Miltenyi Biotec announced today that the U.S. Food and Drug Administration has approved the company's CliniMACS CD34 Reagent System as a Humanitarian Use Device for the prevention of graft-versus-host disease in patients with acute myeloid leukemia in first complete remission undergoing allogeneic stem cell transplantation from a matched related donor.

24 Jan 2014

FDA gives final approval to Perrigo's ANDA for repaglinide tablets 1 mg and 2 mg

Perrigo Company plc today announced that it has received final approval from the U.S. Food & Drug Administration for its abbreviated new drug application for repaglinide tablets 1 mg and 2 mg, the generic equivalent to Prandin Tablets (repaglinide tablets) and has commenced shipment of product. Perrigo previously launched the 0.5 mg strength in 2013.

24 Jan 2014

Research finds spousal diabetes is a diabetes risk factor

Living in a household implies sharing duties and responsibilities but it could also imply sharing your diabetes. A research team from the McGill University Health Centre (MUHC) has shown, through combined analyses of several studies, evidence that spousal diabetes is a diabetes risk factor. These findings, published today in the open access journal BMC Medicine, have important clinical implications since they can help improve diabetes detection and motivate couples to work together to reduce the risk of developing the condition.

24 Jan 2014

Selective FAK inhibition within endothelial cells prevents spontaneous tumor metastasis

A team of scientists, led by principal investigator David D. Schlaepfer, PhD, a professor in the Department of Reproductive Medicine at the University of California, San Diego School of Medicine, has found that a protein involved in promoting tumor growth and survival is also activated in surrounding blood vessels, enabling cancer cells to spread into the bloodstream.

24 Jan 2014

Scientists aim to develop business plan to guide drug development for potential use in patients

What if an experimental treatment for an aggressive breast cancer had the potential to save women's lives, but nobody could use it because there was no money to develop and test it? With funding sources for research and development more scarce than in the past, it is not an unusual situation. It's a problem that Sourav Sinha, a Master's degree candidate at Rutgers' Graduate School of Biomedical Sciences, is working to tackle head-on.

24 Jan 2014

First Edition: January 24, 2014

Today's headlines include reports that a federal district court judge in Missouri has blocked state officials from restricting groups efforts to help people sign up for coverage as part of the federal health law.

24 Jan 2014

Researchers locate two molecules involved in perpetuating chronic pain

Setting the stage for possible advances in pain treatment, researchers at The Johns Hopkins University and the University of Maryland report they have pinpointed two molecules involved in perpetuating chronic pain in mice. The molecules, they say, also appear to have a role in the phenomenon that causes uninjured areas of the body to be more sensitive to pain when an area nearby has been hurt.

24 Jan 2014

Researchers reveal role of extra thymus gland in the network of body's natural defense systems

The thymus gland is a critical component of the human immune system that is responsible for the development of T-lymphocytes, or T-cells, which help organize and lead the body's fighting forces against harmful organisms like bacteria and viruses.

24 Jan 2014

Environmental endocrine disrupters may endanger embryonic heart valves

Exposure to environmental endocrine disrupters, such as bisphenol A, which mimic estrogen, is associated with adverse health effects. Bisphenol A is commonly found in plastic bottles and plastic food containers. New research from a team including Carnegie's Daniel Gorelick and Marnie Halpern on the effects of these chemicals on zebrafish shows that embryonic heart valves could be particularly in danger. It is published by Environmental Health Perspectives.

24 Jan 2014

Big jump in Medicaid signups reported

More than 6.3 million people were found eligible for Medicaid and the Children's Health Insurance Program since October, but it is unclear how many are newly insured since recipients must re-enroll each year. Meanwhile, Health and Human Services Secretary Kathleen Sebelius urges mayors to push their states to expand the program. News outlets also look at developments in Virginia and Florida.

24 Jan 2014

Many serious diseases come from the air that we breathe every day

At rest, we breathe approx. 12-15 times per minute, and for each inhalation we change approx. one litre of air. Depending on the activity level, this makes up a daily quantity in the order of twenty cubic metres of air that - with its content of pollution in the form of particles and different gases - can make us ill depending on how polluted the air is.

24 Jan 2014

Comprehensive supplement released on Thomas L. Petty Aspen Lung Conference

The Annals of the American Thoracic Society has released a comprehensive supplement on the 56th annual Thomas L. Petty Aspen Lung Conference entitled "The Lung Microbiome: A New Frontier in Pulmonary Medicine."

24 Jan 2014

Simple protein test useful in predicting survival chances for patients with head-and-neck cancer

Scientists from The University of Manchester - part of the Manchester Cancer Research Centre - used a simple protein test that could prove more useful in predicting survival chances for patients with head-and-neck cancer compared to existing methods.

24 Jan 2014

Medical News

Researchers suggest possible novel target for seizure-blocking medicines

Medicaid 'death debt' causes some to step away from coverage

Early onset of dietary treatment may slow down progression of Alzheimer's disease

New approaches for emerging technique in diagnostic imaging for breast cancer-MRI with NIRS

TherapeuticsMD starts TX 12-002-HR phase 3 clinical trial for secondary amenorrhea

Bristol-Myers Squibb fourth quarter 2013 revenues increase 6% to $4.4 billion

Political cartoon: 'Friends With Benefits?'

FDA approves Miltenyi Biotec's CliniMACS CD34 Reagent System for prevention of GVHD

FDA gives final approval to Perrigo's ANDA for repaglinide tablets 1 mg and 2 mg

Research finds spousal diabetes is a diabetes risk factor

Selective FAK inhibition within endothelial cells prevents spontaneous tumor metastasis

Scientists aim to develop business plan to guide drug development for potential use in patients

First Edition: January 24, 2014

Researchers locate two molecules involved in perpetuating chronic pain

Researchers reveal role of extra thymus gland in the network of body's natural defense systems

Environmental endocrine disrupters may endanger embryonic heart valves

Big jump in Medicaid signups reported

Many serious diseases come from the air that we breathe every day

Comprehensive supplement released on Thomas L. Petty Aspen Lung Conference

Simple protein test useful in predicting survival chances for patients with head-and-neck cancer

Directed enzyme evolution and the Nobel Prize: Making enzymes evolve in the lab

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Latest News